ABRACL

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ABRACL mutation is significantly associated with the RNA expression of many other genes, with 13 significant associations in total. LUAD shows the largest number of these associations.

The most reproducible ABRACL-associated genes across cancer lineages are IGHD5-5, MIR1298, and RNA5SP405. Each is linked with ABRACL in more than 1 cancer types. Because this analysis shows association rather than direction, both ABRACL-to-partner and partner-to-ABRACL results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IGHD5-5 grouped by ABRACL-low versus ABRACL-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ABRACL→partner) and Y-score (partner→ABRACL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECIGHD5-5 →+1.131+8.066<.001.00731
UCECMIR1298 →+0.373+8.066<.001.00731
LUADRNA5SP405 →+0.328+7.930<.001.00831
LUADRNU6-472P →+0.342+7.930<.001.00831
LUADMIR655 →+0.617+7.930<.001.00831
LUADMIR552 →+0.803+7.930<.001.00831
Each partner links to its Q-omics profile. Showing the 6 strongest of 13 associations by consensus.

IGHD5-5 by ABRACL expression — UCEC

Box plot of IGHD5-5 in ABRACL-low vs ABRACL-high samples in UCEC.

Explore this box plot interactively →

Exploration